Recruiting Xerostomia Studies in Baltimore
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
This study will assess the efficacy and safety of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia....
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
This is a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult patients with radiation-induced xerostomia...
About Xerostomia Clinical Trials in Baltimore
Xerostomia (dry mouth) is a condition where the salivary glands do not produce enough saliva to keep the mouth moist. It can result from medications, radiation therapy, or autoimmune conditions. Treatment includes saliva substitutes, medications to stimulate saliva production, and dental care.
There are currently 2 xerostomia clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 318 participants. Research is being sponsored by MeiraGTx, LLC, RiboX Therapeutics Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xerostomia Clinical Trials in Baltimore — FAQ
Are there xerostomia clinical trials in Baltimore?
Yes, there are 2 xerostomia clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What xerostomia treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for xerostomia.
Data updated March 2, 2026 from ClinicalTrials.gov